Pharmacyclics Enters Into Agreement With Roche To Evaluate IMBRUVICA And GAZYVA In Lymphoma And Leukemia

By: via Benzinga
Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that it has entered into a master clinical drug supply agreement with Roche (SIX: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.